Shpetim Karandrea, N. Agarwal, Organizing Committee of Cardiometabolic Health Congress Organizing Committee of Cardiometabolic Health Con
{"title":"Report from the Scientific Poster Session at the 16th Annual Cardiometabolic Health Congress in National Harbor, USA, 14–17 October 2021","authors":"Shpetim Karandrea, N. Agarwal, Organizing Committee of Cardiometabolic Health Congress Organizing Committee of Cardiometabolic Health Con","doi":"10.3390/proceedings2022080006","DOIUrl":null,"url":null,"abstract":"Purpose: Prior studies have documented a higher prevalence of heart failure (HF) in the non-black gout population. Literature has shown a systolic dysfunction of about 12.7% among the Framingham Offspring cohort. Using clinical and echocardiographic data, we aimed to compare the characteristics of left ventricular dysfunction and associated risk factors of HF in Black patients with and without gout. Methods: Cross-sectional analysis of electronic medical record data of gout patients was compared to age, sex, and race matched cohort of the non-gout patients. Clinical parameters and 2D echocardiograms were reviewed for the patients with gout and heart failure. Left ventricular ejection fraction (LVEF), left ventricular wall motion and size abnormalities, and diastolic dysfunction was evaluated. HF patients with gout were further categorized based on LVEF % into three groups: <40%, 41–55% and >55%. Descriptive statistics using SPSS version 29 was applied; a logistic regression model was used to assess the strength of association between HF and cardiovascular risk factors. Results: The gout population of 471 patients with a mean age of 63.7 ± 0.53 years, 89% being Black, and 63% men were compared to an age, sex, race matched non-gout cohort. Body mass index (BMI) for those with gout was 31.3 ± 0","PeriodicalId":166036,"journal":{"name":"Stand Alone Papers 2022","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stand Alone Papers 2022","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/proceedings2022080006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Prior studies have documented a higher prevalence of heart failure (HF) in the non-black gout population. Literature has shown a systolic dysfunction of about 12.7% among the Framingham Offspring cohort. Using clinical and echocardiographic data, we aimed to compare the characteristics of left ventricular dysfunction and associated risk factors of HF in Black patients with and without gout. Methods: Cross-sectional analysis of electronic medical record data of gout patients was compared to age, sex, and race matched cohort of the non-gout patients. Clinical parameters and 2D echocardiograms were reviewed for the patients with gout and heart failure. Left ventricular ejection fraction (LVEF), left ventricular wall motion and size abnormalities, and diastolic dysfunction was evaluated. HF patients with gout were further categorized based on LVEF % into three groups: <40%, 41–55% and >55%. Descriptive statistics using SPSS version 29 was applied; a logistic regression model was used to assess the strength of association between HF and cardiovascular risk factors. Results: The gout population of 471 patients with a mean age of 63.7 ± 0.53 years, 89% being Black, and 63% men were compared to an age, sex, race matched non-gout cohort. Body mass index (BMI) for those with gout was 31.3 ± 0